BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36719115)

  • 1. [Oxidative stress in the pathogenesis of stroke and its correction].
    Martynov MY; Zhuravleva MV; Vasyukova NS; Kuznetsova EV; Kameneva TR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):16-27. PubMed ID: 36719115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with ischemic stroke].
    Zhuravleva MV; Shchukin IA; Fidler MS; Prokofiev AB; Serebrova SY; Vasyukova NS; Demchenkova EY; Arkhipov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):60-66. PubMed ID: 33449535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An effect of ethylmethylhydroxypyridine succinate and ethylmethylhydroxypyridine malate on changes in mitochondrial function under conditions of focal cerebral ischemia].
    Pozdnyakov DI; Zolotykh DS; Vihor AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11):111-116. PubMed ID: 37994896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vascular inflammation underlies the development of atherothrombotic stroke].
    Romanenko AV; Amelina IP; Solovyeva EY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8. Vyp. 2):22-29. PubMed ID: 34553577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: Opportunities, challenges and future directions for cerebral stroke management.
    Rana AK; Singh D
    Neuropharmacology; 2018 Sep; 139():124-136. PubMed ID: 30017999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern strategies of protection of hypoxic-ischemic brain damage].
    Yanishevsky SN; Tsygan NV; Golokhvastov SY; Andreev RV; Litvinenko IV; Karpova OS; Yakovleva VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12. Vyp. 2):78-86. PubMed ID: 29411750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].
    Stakhovskaya LV; Shamalov NA; Khasanova DR; Melnikova EV; Agafiina AS; Golikov KV; Bogdanov EI; Yakupova AA; Roshkovskaya LV; Lukinykh LV; Lokshtanova TM; Poverennova IE; Shepankevich LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3. Vyp. 2):55-65. PubMed ID: 28665371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of free-radical oxidation as a pathogenetic approach to the treatment of acute ischemic stroke].
    Chugunov AV; Kamchatnov PR; Mikhaĭlova NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10 Suppl 2):65-8. PubMed ID: 20229636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Polyphenols as Antioxidant Supplementation in Ischemic Stroke.
    Zhou Y; Zhang S; Fan X
    Oxid Med Cell Longev; 2021; 2021():5471347. PubMed ID: 34257802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of therapy with Mexidol on neurological deficit and functional outcome in patients with ischemic stroke: a systematic review and meta-analysis].
    Voznyuk IA; Kolomentsev SV; Morozova EM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12. Vyp. 2):49-60. PubMed ID: 38148698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA)].
    Stakhovskaya LV; Mkhitaryan EA; Tkacheva ON; Ostroumova TM; Ostroumova OD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8. Vyp. 2):49-57. PubMed ID: 33016677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of Ischemic Stroke: Role of Oxidative Stress.
    Orellana-Urzúa S; Rojas I; Líbano L; Rodrigo R
    Curr Pharm Des; 2020; 26(34):4246-4260. PubMed ID: 32640953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection against oxidative injury by a nucleic acid-based health product (Squina DNA) through enhancing mitochondrial antioxidant status and functional capacity.
    Lam PY; Chen N; Chiu PY; Leung HY; Ko KM
    J Med Food; 2012 Jul; 15(7):629-38. PubMed ID: 22612294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of oxidative stress in hemorrhagic stroke and restorative effects of Mexidol].
    Voronina TA; Kraineva VA; Zolotov NN; Kotel'nikova SO; Val'dman EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8. Vyp. 2):65-71. PubMed ID: 36036146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of clinical studies of the efficacy and safety of the use of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].
    Zhuravleva MV; Kamchatnov PR; Vasyukova NS; Arkhipov VV; Kuznetsova EV; Kameneva TR; Serebrova SY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):29-39. PubMed ID: 36440774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
    Kelly PJ; Morrow JD; Ning M; Koroshetz W; Lo EH; Terry E; Milne GL; Hubbard J; Lee H; Stevenson E; Lederer M; Furie KL
    Stroke; 2008 Jan; 39(1):100-4. PubMed ID: 18063832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities.
    Rodrigo R; Fernández-Gajardo R; Gutiérrez R; Matamala JM; Carrasco R; Miranda-Merchak A; Feuerhake W
    CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):698-714. PubMed ID: 23469845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free radical scavengers and spin traps--therapeutic implications for ischemic stroke.
    Doeppner TR; Hermann DM
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):511-20. PubMed ID: 21619863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacoeconomic analysis of the neuroprotective medicines in the treatment of ischemic stroke].
    Yagudina RI; Kulikov AY; Krylov VA; Solovieva EY; Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):60-68. PubMed ID: 31464291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal administration of β-1, 3-galactosyltransferase 2 confers neuroprotection against ischemic stroke by likely inhibiting oxidative stress and NLRP3 inflammasome activation.
    Guo X; Zhang Y; Liu C; Ren L; Gao S; Bi J; Liang J; Wang P
    FASEB J; 2022 Oct; 36(10):e22542. PubMed ID: 36094000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.